Does SARS-CoV-2 has a longer incubation period than SARS and MERS?

Journal of Medical Virology

Volumn 92, Issue 5, 2020, Pages 476-478

  Jiang, Xuan ^a,b   Rayner, Simon ^b,c,d   Luo, Min Hua ^a,b,e,f  

^a Guangzhou Women and Children's Medical Center   (China)

^b WUHAN INSTITUTE OF VIROLOGY   (China)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e Shenzhen Fundamental Research Institutions   (China)

^f UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

coronavirus; incubation; local infection replication spread; pandemic; virulence

Indexed keywords

CHINA; CLINICAL FEATURE; CORONAVIRUS DISEASE 2019; CORONAVIRUS INFECTION; EPIDEMIC; INCUBATION TIME; INFECTION CONTROL; INFECTION RESISTANCE; INFECTION RISK; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; NOTE; OUTCOME ASSESSMENT; SARS CORONAVIRUS; SCREENING TEST; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SPECIES COMPARISON; STRAIN DIFFERENCE; VIRUS ISOLATION; VIRUS TRANSMISSION; BASIC REPRODUCTION NUMBER; BETACORONAVIRUS; HUMAN; INFORMATION PROCESSING; PATHOGENICITY; PATHOLOGY; SEVERE ACUTE RESPIRATORY SYNDROME; TIME FACTOR; VIROLOGY; VIRUS PNEUMONIA;

COVID-19; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2;

BASIC REPRODUCTION NUMBER; BETACORONAVIRUS; CHINA; CORONAVIRUS INFECTIONS; DATASETS AS TOPIC; HUMANS; INFECTIOUS DISEASE INCUBATION PERIOD; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; PNEUMONIA, VIRAL; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; TIME FACTORS;

EID: 85081330940     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.25708     Document Type: Note

References (10)

1. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020. https://doi.org/NEJMoa2001017
2. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020.
3. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497-506.
4. National Health Commission of the People's Republic of China, 2020. http://www.nhc.gov.cn/xcs/yqtb/202002/6c305f6d70f545d59548ba17d79b8229.shtml
5. Munster VJ, Koopmans M, van Doremalen N, van Riel D, de Wit E. A novel coronavirus emerging in China—Key questions for impact assessment. N Engl J Med. 2020. https://doi.org/10.1056/NEJMp2000929
6. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med.
7. Lessler J, Reich NG, Brookmeyer R, Perl TM, Nelson KE, Cummings DA. Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis. 2009;9(5):291-300.
8. Park JE, Jung S, Kim A, Park JE. MERS transmission and risk factors: a systematic review. BMC Public Health. 2018;18(1):574.
9. Backer JA, Klinkenberg D, Wallinga J. The incubation period of 2019-nCoV infections among travellers from Wuhan, China. medRxiv. 2020. https://doi.org/10.1101/2020.01.27.20018986
10. Sun K, Online repository, 2020. https://docs.google.com/spreadsheets/d/1jS24DjSPVWa4iuxuD4OAXrE3QeI8c9BC1hSlqrNMiU/edit#gid=1449891965